145 related articles for article (PubMed ID: 24914470)
1. Luteolin modulates expression of drug-metabolizing enzymes through the AhR and Nrf2 pathways in hepatic cells.
Zhang T; Kimura Y; Jiang S; Harada K; Yamashita Y; Ashida H
Arch Biochem Biophys; 2014 Sep; 557():36-46. PubMed ID: 24914470
[TBL] [Abstract][Full Text] [Related]
2. The aryl hydrocarbon receptor interacts with nuclear factor erythroid 2-related factor 2 to mediate induction of NAD(P)H:quinoneoxidoreductase 1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Wang L; He X; Szklarz GD; Bi Y; Rojanasakul Y; Ma Q
Arch Biochem Biophys; 2013 Sep; 537(1):31-8. PubMed ID: 23800876
[TBL] [Abstract][Full Text] [Related]
3. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction.
Ma Q; Kinneer K; Bi Y; Chan JY; Kan YW
Biochem J; 2004 Jan; 377(Pt 1):205-13. PubMed ID: 14510636
[TBL] [Abstract][Full Text] [Related]
4. Omeprazole induces NAD(P)H quinone oxidoreductase 1 via aryl hydrocarbon receptor-independent mechanisms: Role of the transcription factor nuclear factor erythroid 2-related factor 2.
Zhang S; Patel A; Moorthy B; Shivanna B
Biochem Biophys Res Commun; 2015 Nov; 467(2):282-7. PubMed ID: 26441083
[TBL] [Abstract][Full Text] [Related]
5. Kaempferol modulates TCDD- and t-BHQ-induced drug-metabolizing enzymes and luteolin enhances this effect.
Kitakaze T; Makiyama A; Nakai R; Kimura Y; Ashida H
Food Funct; 2020 Apr; 11(4):3668-3680. PubMed ID: 32301455
[TBL] [Abstract][Full Text] [Related]
6. Curcumin and its derivatives inhibit 2,3,7,8,-tetrachloro-dibenzo-p-dioxin-induced expression of drug metabolizing enzymes through aryl hydrocarbon receptor-mediated pathway.
Nakai R; Fukuda S; Kawase M; Yamashita Y; Ashida H
Biosci Biotechnol Biochem; 2018 Apr; 82(4):616-628. PubMed ID: 29191105
[TBL] [Abstract][Full Text] [Related]
7. Methylated pentavalent arsenic metabolites are bifunctional inducers, as they induce cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase through AhR- and Nrf2-dependent mechanisms.
Anwar-Mohamed A; Elshenawy OH; Soshilov AA; Denison MS; Chris Le X; Klotz LO; El-Kadi AO
Free Radic Biol Med; 2014 Feb; 67():171-87. PubMed ID: 24161444
[TBL] [Abstract][Full Text] [Related]
8. Introducing the "TCDD-inducible AhR-Nrf2 gene battery".
Yeager RL; Reisman SA; Aleksunes LM; Klaassen CD
Toxicol Sci; 2009 Oct; 111(2):238-46. PubMed ID: 19474220
[TBL] [Abstract][Full Text] [Related]
9. Shikonin upregulates the expression of drug-metabolizing enzymes and drug transporters in primary rat hepatocytes.
Huang CS; Chen HW; Lin TY; Lin AH; Lii CK
J Ethnopharmacol; 2018 Apr; 216():18-25. PubMed ID: 29414119
[TBL] [Abstract][Full Text] [Related]
10. A physiological concentration of luteolin induces phase II drug-metabolizing enzymes through the ERK1/2 signaling pathway in HepG2 cells.
Kitakaze T; Makiyama A; Samukawa Y; Jiang S; Yamashita Y; Ashida H
Arch Biochem Biophys; 2019 Mar; 663():151-159. PubMed ID: 30641047
[TBL] [Abstract][Full Text] [Related]
11. The aryl hydrocarbon receptor and estrogen receptor alpha differentially modulate nuclear factor erythroid-2-related factor 2 transactivation in MCF-7 breast cancer cells.
Lo R; Matthews J
Toxicol Appl Pharmacol; 2013 Jul; 270(2):139-48. PubMed ID: 23583297
[TBL] [Abstract][Full Text] [Related]
12. Induction of detoxifying enzymes in rodent white adipose tissue by aryl hydrocarbon receptor agonists and antioxidants.
Yoshinari K; Okino N; Sato T; Sugatani J; Miwa M
Drug Metab Dispos; 2006 Jul; 34(7):1081-9. PubMed ID: 16581946
[TBL] [Abstract][Full Text] [Related]
13. Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-null mice.
Aleksunes LM; Klaassen CD
Drug Metab Dispos; 2012 Jul; 40(7):1366-79. PubMed ID: 22496397
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of the diterpenoid 14-deoxy-11,12-didehydroandrographolide in rats and up-regulation of hepatic drug-metabolizing enzyme and drug transporter expression.
Yen CC; Liu YT; Lin YJ; Yang YC; Chen CC; Yao HT; Chen HW; Lii CK
Phytomedicine; 2019 Aug; 61():152841. PubMed ID: 31035043
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia perturbs aryl hydrocarbon receptor signaling and CYP1A1 expression induced by PCB 126 in human skin and liver-derived cell lines.
Vorrink SU; Severson PL; Kulak MV; Futscher BW; Domann FE
Toxicol Appl Pharmacol; 2014 Feb; 274(3):408-16. PubMed ID: 24355420
[TBL] [Abstract][Full Text] [Related]
16. Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.
Chian S; Thapa R; Chi Z; Wang XJ; Tang X
Biochem Biophys Res Commun; 2014 May; 447(4):602-8. PubMed ID: 24747074
[TBL] [Abstract][Full Text] [Related]
17. TCDD dysregulation of 13 AHR-target genes in rat liver.
Watson JD; Prokopec SD; Smith AB; Okey AB; Pohjanvirta R; Boutros PC
Toxicol Appl Pharmacol; 2014 Feb; 274(3):445-54. PubMed ID: 24355419
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Hepatic NRF2 and Aryl Hydrocarbon Receptor Binding in 2,3,7,8-Tetrachlorodibenzo-
Nault R; Doskey CM; Fader KA; Rockwell CE; Zacharewski T
Mol Pharmacol; 2018 Aug; 94(2):876-884. PubMed ID: 29752288
[TBL] [Abstract][Full Text] [Related]
19. The role of aryl hydrocarbon receptor in regulation of enzymes involved in metabolic activation of polycyclic aromatic hydrocarbons in a model of rat liver progenitor cells.
Vondrácek J; Krcmár P; Procházková J; Trilecová L; Gavelová M; Skálová L; Szotáková B; Buncek M; Radilová H; Kozubík A; Machala M
Chem Biol Interact; 2009 Jul; 180(2):226-37. PubMed ID: 19497421
[TBL] [Abstract][Full Text] [Related]
20. Cynaropicrin attenuates UVB-induced oxidative stress via the AhR-Nrf2-Nqo1 pathway.
Takei K; Hashimoto-Hachiya A; Takahara M; Tsuji G; Nakahara T; Furue M
Toxicol Lett; 2015 Apr; 234(2):74-80. PubMed ID: 25680693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
